EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Ferric Derisomaltose Augments Intrinsic Skeletal Muscle Electron Transport Chain Activity in Heart Failure: A FERRIC-HF II Molecular Substudy

Mohamad F Barakat, Nelson Amaral, Daniel Brayson, George Amin-Youssef, Huda Abu-Own, Salma Ayis, Francesco Papalia, Fadi Jouhra, Adam Nabeebaccus, Mark Monaghan, Gerry Carr-White, Alison Sleigh und 5 weitere

European Journal of Heart Failure · 01.11.2025 · 27 (11) · 2343-2351

DOI: 10.1002/ejhf.70028 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Heart Failure, online erschienen am 08.09.2025. Verfasst von Mohamad F Barakat und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular & Metabolic Medicine and Science, James Black Centre, King's College London British Heart Foundation Centre of Excellence, L…. Hauptthemen laut MEDLINE: Heart Failure, Muscle, Skeletal, Maltose, Ferric Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Skeletal muscle energetic augmentation might be a mechanism via which intravenous iron improves symptoms in heart failure, but no direct measurement of intrinsic mitochondrial function has been performed to support this notion. This molecular substudy of the FERRIC-HF II trial tested the hypothesis that ferric derisomaltose (FDI) would improve electron transport chain activity, given its high dependence on iron–sulfur clusters which facilitate electron transfer during oxidative phosphorylation. Methods and results Vastus lateralis skeletal muscle biopsies were taken before and 2 weeks after randomization. Mitochondrial complex I, II, and I&II respiration were quantified with respirometry of permeabilized fresh skeletal muscle biopsies. Net respiratory capacities, reflecting respiration that is truly available for adenosine triphosphate generation, were calculated by subtracting non-phosphorylating LEAK respiration. Complex I–V and myoglobin protein levels, and skeletal muscle fibre type composition were assayed. Patients randomised to FDI (n = 21) or placebo (n = 19) were similar (age 66 ± 13 years, 73% men, left ventricular ejection fraction 37 ± 8%, 48% New York Heart Association class III, 50% diabetic). After 2 weeks, total complex I-linked respiration (0.33 [interquartile range 0.24–0.37] vs. 0.19 [0.06–0.27] nmol/min/mg, p = 0.03) and net complex I-linked respiration (0.21 [0.16–0.24] vs. 0.11 [0.04–0.16] nmol/min/mg, p = 0.01) were higher in patients allocated to FDI. There was no intergroup difference in other respiratory states, in mitochondrial abundance as reflected by complex I–V protein levels, and in skeletal muscle myoglobin and oxidative fibre type content.

Conclusions

Iron repletion induces an early, selective, and potentially direct enhancement of mitochondrial complex I-dependent respiration in the skeletal muscle of heart failure patients. This could be harnessed to optimize repletion protocols to maximize patient benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMuscle, SkeletalMaltoseFerric CompoundsHumansMaleFemaleAgedMiddle AgedElectron TransportMitochondria, MuscleOxidative PhosphorylationElectron Transport Complex IBiopsyElectron Transport Complex II

Stichwörter der Autor:innen

EnergeticsHeart failureIronMitochondriaMuscleRespirometry

Substanzen

MaltoseFerric CompoundsElectron Transport Complex IElectron Transport Complex II

Autor:innen und Institutionen

  • School of Cardiovascular & Metabolic Medicine and Science, James Black Centre, King's College London British Heart Foundation Centre of Excellence, London, UK.
  • School of Life Sciences, University of Westminster.
  • King's College Hospital NHS Foundation Trust, London, UK.
  • School of Population Health and Environmental Sciences, King's College, London, UK.
  • Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Wolfson Brain Imaging Centre, University of Cambridge School of Clinical Medicine, Cambridge, UK.

Förderung

  • British Heart Foundation

Zitieren

APA

Barakat, M. F., Amaral, N., Brayson, D., Amin-Youssef, G., Abu-Own, H., Ayis, S., Papalia, F., Jouhra, F., Nabeebaccus, A., Monaghan, M., Carr-White, G., Sleigh, A., Charles-Edwards, G., Shah, A. M., Kemp, G. J., Murray, A. J., & Okonko, D. O. (2025). Ferric Derisomaltose Augments Intrinsic Skeletal Muscle Electron Transport Chain Activity in Heart Failure: A FERRIC-HF II Molecular Substudy. European Journal of Heart Failure, 27(11), 2343-2351. https://doi.org/10.1002/ejhf.70028

Vancouver

Barakat MF, Amaral N, Brayson D, Amin-Youssef G, Abu-Own H, Ayis S, et al. Ferric Derisomaltose Augments Intrinsic Skeletal Muscle Electron Transport Chain Activity in Heart Failure: A FERRIC-HF II Molecular Substudy. European Journal of Heart Failure. 2025;27(11):2343-2351. doi:10.1002/ejhf.70028

BibTeX
@article{Barakat2025,
  author = {Barakat, Mohamad F and Amaral, Nelson and Brayson, Daniel and Amin-Youssef, George and Abu-Own, Huda and Ayis, Salma and Papalia, Francesco and Jouhra, Fadi and Nabeebaccus, Adam and Monaghan, Mark and Carr-White, Gerry and Sleigh, Alison and Charles-Edwards, Geoffrey and Shah, Ajay M and Kemp, Graham J and Murray, Andrew J and Okonko, Darlington O},
  title = {Ferric Derisomaltose Augments Intrinsic Skeletal Muscle Electron Transport Chain Activity in Heart Failure: A FERRIC-HF II Molecular Substudy},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {11},
  pages = {2343--2351},
  doi = {10.1002/ejhf.70028}
}
Kostenlos starten →